The history and regulatory mechanism of the Hippo pathway

키워드

참고문헌 (152)

1. Shingleton AW, "The regulation of organ size in Drosophila: physiology, plasticity, patterning and physical force", Organogenesis, 6, pp.76~87 (2010)[DOI]
2. Gokhale RH, "Size control: the developmental physiology of body and organ size regulation", Wiley Interdiscip Rev Dev Biol, 4, pp.335~356 (2015)[DOI]
3. Halder G, "Hippo signaling: growth control and beyond", Development, 138, pp.9~22 (2011)[DOI]
4. Twitty VCS, "The growth of eyes and limbs transplanted heteroplastically between two species of Amblystoma", J Exp Zool, 59, pp.61~86 (1931)[DOI]
5. Michalopoulos GK, "Liver regeneration", Science, 276, pp.60~66 (1997)[DOI]
6. Metcalf D, "Restricted Growth Capacity of Multiple Spleen Grafts", Transplantation, 2, pp.387~392 (1964)[DOI]
7. Metcalf D, "The Autonomous Behaviour of Normal Thymus Grafts", Aust J Exp Biol Med Sci, 41(SUPPL), pp.437~447 (1963)[DOI]
8. Hilman D, "The evolutionary history of YAP and the hippo", YAP pathway, 2011, pp.28, 2403~2417
9. Sebe-Pedros A, "Premetazoan origin of the hippo signaling pathway", Cell Rep, 1, pp.13~20 (2012)[DOI]
10. Huang J, "The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP", Cell, 122, pp.421~434 (2005)[DOI]
11. Meng Z, "Mechanisms of Hippo pathway regulation", Genes Dev, 30, pp.1~17 (2016)[DOI]
12. Piccolo S, "The biology of YAP", TAZ: hippo signaling and beyond, 2014, pp.94, 1287~1312
13. Zhao B, "A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)", Genes Dev, 24, pp.72~85 (2010)[DOI]
14. Liu CY, "The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase", J Biol Chem, 285, pp.37159~37169 (2010)[DOI]
15. Huang W, "The N-terminal phosphodegron targets TAZ", WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition, 2012, pp.287, 26245~26253
16. Hansen CG, "YAP and TAZ: a nexus for Hippo signaling and beyond", Trends Cell Biol, 25, pp.499~513 (2015)[DOI]
17. Meng Z, "MAP4K family kinases act in parallel to MST1", 2 to activate LATS1, Nat Commun, pp.2015, 6[DOI]
18. Kim Y, "Deubiquitinase YOD1 potentiates YAP", TAZ activities through enhancing ITCH stability, 2017, pp.114, 4691~4696
19. Yin F, "Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin", NF2, 2013, pp.154, 1342~1355
20. Fulford A, "Upstairs, downstairs: spatial regulation of Hippo signalling", Curr Opin Cell Biol, 51, pp.22~32 (2017)
21. Chaulk SG, "The Hippo pathway effectors TAZ", YAP regulate dicer expression and microRNA biogenesis through Let-7, 2014, pp.289, 1886~1891
22. Mori M, "Hippo signaling regulates microprocessor and links celldensity- dependent miRNA biogenesis to cancer", Cell, 156, pp.893~906 (2014)[DOI]
23. Sabine A, "FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature", J Clin Invest, 125, pp.3861~3877 (2015)[DOI]
24. Wang L, "Integrin-YAP", TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow, 2016, pp.540, 579~582
25. Liu B, "Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila", Cell, 164, pp.406~419 (2016)[DOI]
26. Wang S, "YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKvarepsilon-mediated phosphorylation", Nat Immunol, 18, pp.733~743 (2017)[DOI]
27. Wilkinson DS, "Phosphorylation of LC3 by the Hippo kinases STK3", STK4 is essential for autophagy, 2015, pp.57, 55~68
28. Maejima Y, "Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2", Nat Med, 19, pp.1478~1488 (2013)[DOI]
29. Zhang S, "Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2", Cancer Cell, 31, pp.669~684 (2017)[DOI]
30. Justice RW, "The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation", Genes Dev, 9, pp.534~546 (1995)[DOI]
31. Xu T, "Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase", Development, 121, pp.1053~1063 (1995)
32. St John MA, "Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction", Nat Genet, 21, pp.182~186 (1999)[DOI]
33. Tao W, "Human homologue of the Drosophila melanogaster lats tumour suppressor modulates CDC2 activity", Nat Genet, 21, pp.177~181 (1999)[DOI]
34. Tapon N, "salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines", Cell, 110, pp.467~478 (2002)[DOI]
35. Kango-Singh M, "Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila", Development, 129, pp.5719~5730 (2002)[DOI]
36. Harvey KF, "The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis", Cell, 114, pp.457~467 (2003)[DOI]
37. Udan RS, "Hippo promotes proliferation arrest and apoptosis in the Salvador", Warts pathway, 2003, pp.5, 914~920
38. Pantalacci S, "The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila", Nat Cell Biol, 5, pp.921~927 (2003)[DOI]
39. Jia J, "The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis", Genes Dev, 17, pp.2514~2519 (2003)[DOI]
40. Wu S, "hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts", Cell, 114, pp.445~456 (2003)[DOI]
41. Lai ZC, "Control of cell proliferation and apoptosis by mob as tumor suppressor, mats", Cell, 120, pp.675~685 (2005)[DOI]
42. Wei X, "Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila", EMBO J, 26, pp.1772~1781 (2007)[DOI]
43. Zhao B, "Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control", Genes Dev, 21, pp.2747~2761 (2007)[DOI]
44. Zhang N, "The Merlin", NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals, 2010, pp.19, 27~38
45. Overholtzer M, "Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon", Proc Natl Acad Sci U S A, 103, pp.12405~12410 (2006)[DOI]
46. Harvey KF, "The Hippo pathway and human cancer", Nat Rev Cancer, 13, pp.246~257 (2013)[DOI]
47. Johnson R, "The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment", Nat Rev Drug Discov, 13, pp.63~79 (2014)[DOI]
48. Moroishi T, "The emerging roles of YAP and TAZ in cancer", Nat Rev Cancer, 15, pp.73~79 (2015)[DOI]
49. Sudol M, "Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product", Oncogene, 9, pp.2145~2152 (1994)
50. Komuro A, "WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus", J Biol Chem, 278, pp.33334~33341 (2003)[DOI]
51. Ferrigno O, "Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta", Smad signaling, 2002, pp.21, 4879~4884
52. Strano S, "Physical interaction with Yes-associated protein enhances p73 transcriptional activity", J Biol Chem, 276, pp.15164~15173 (2001)[DOI]
53. Zaidi SK, "Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription", EMBO J, 23, pp.790~799 (2004)[DOI]
54. Vassilev A, "TEAD", TEF transcription factors utilize the activation domain of YAP65, a Src, Genes Dev, pp.2001, 15[DOI]
55. Yagi R, "A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator", EMBO J, 18, pp.2551~2562 (1999)[DOI]
56. Espanel X, "Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains", J Biol Chem, 276, pp.14514~14523 (2001)[DOI]
57. Ota M, "Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling", Development, 135, pp.4059~4069 (2008)[DOI]
58. Wu S, "The TEAD", TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway, 2008, pp.14, 388~398
59. Zhang L, "The TEAD", TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control, 2008, pp.14, 377~387
60. Zhao B, "TEAD mediates YAP-dependent gene induction and growth control", Genes Dev, 22, pp.1962~1971 (2008)[DOI]
61. Schlegelmilch K, "Yap1 acts downstream of alpha-catenin to control epidermal proliferation", Cell, 144, pp.782~795 (2011)[DOI]
62. von Gise A, "YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy", Proc Natl Acad Sci U S A, 109, pp.2394~2399 (2012)[DOI]
63. Zhang W, "VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex", Cell Res, 24, pp.331~343 (2014)[DOI]
64. Koontz LM, "The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression", Dev Cell, 25, pp.388~401 (2013)[DOI]
65. Hamaratoglu F, "The tumour-suppressor genes NF2", Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis, 2006, pp.8, 27~36
66. Willecke M, "The fat cadherin acts through the hippo tumorsuppressor pathway to regulate tissue size", Curr Biol, 16, pp.2090~2100 (2006)[DOI]
67. Silva E, "The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway", Curr Biol, 16, pp.2081~2089 (2006)[DOI]
68. Cho E, "Delineation of a Fat tumor suppressor pathway", Nat Genet, 38, pp.1142~1150 (2006)[DOI]
69. Poon CL, "The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway", Dev Cell, 21, pp.896~906 (2011)[DOI]
70. Boggiano JC, "Tao-1 phosphorylates Hippo", MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway, 2011, pp.21, 888~895
71. Chung HL, "Drosophila Schip1 Links Expanded and Tao-1 to Regulate Hippo Signaling", Dev Cell, 36, pp.511~524 (2016)[DOI]
72. Yu J, "Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded", Dev Cell, 18, pp.288~299 (2010)[DOI]
73. Genevet A, "Kibra is a regulator of the Salvador", Warts, Dev Cell, pp.2010, 18[DOI]
74. Baumgartner R, "The WW domain protein Kibra acts upstream of Hippo in Drosophila", Dev Cell, 18, pp.309~316 (2010)[DOI]
75. Su T, "Kibra and Merlin Activate the Hippo Pathway Spatially Distinct from and Independent of Expanded", Dev Cell, 40, pp.478~490 (2017)[DOI]
76. Thompson BJ, "Sticking together the Crumbs - an unexpected function for an old friend", Nat Rev Mol Cell Biol, 14, pp.307~314 (2013)
77. Chen CL, "The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila", Proc Natl Acad Sci U S A, 107, pp.15810~15815 (2010)[DOI]
78. Ling C, "The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded", Proc Natl Acad Sci U S A, 107, pp.10532~10537 (2010)[DOI]
79. Grzeschik NA, "Lgl, aPKC, and Crumbs regulate the Salvador", Warts, Curr Biol, pp.2010, 20[DOI]
80. Varelas X, "The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta- SMAD pathway", Dev Cell, 19, pp.831~844 (2010)[DOI]
81. Hirano S, "Identification of a neural alphacatenin as a key regulator of cadherin function and multicellular organization", Cell, 70, pp.293~301 (1992)[DOI]
82. Herrenknecht K, "The uvomorulin-anchorage protein alpha catenin is a vinculin homologue", Proc Natl Acad Sci U S A, 88, pp.9156~9160 (1991)[DOI]
83. Silvis MR, "alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1", Sci Signal, 4, pp.ra33~ (2011)
84. Wei SY, "Echinoid is a component of adherens junctions that cooperates with DE-Cadherin to mediate cell adhesion", Dev Cell, 8, pp.493~504 (2005)[DOI]
85. Yue T, "The cell adhesion molecule echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway", Dev Cell, 22, pp.255~267 (2012)[DOI]
86. Nishioka N, "The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass", Dev Cell, 16, pp.398~410 (2009)[DOI]
87. Wang W, "PTPN14 is required for the density-dependent control of YAP1", Genes Dev, 26, pp.1959~1971 (2012)[DOI]
88. Liu X, "PTPN14 interacts with and negatively regulates the oncogenic function of YAP", Oncogene, 32, pp.1266~1273 (2013)[DOI]
89. Michaloglou C, "The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity", PLoS One, 8, pp.e61916~ (2013)[DOI]
90. Moon S, "Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization", EMBO Rep, 18, pp.61~71 (2017)[DOI]
91. Dupont S, "Role of YAP", TAZ in mechanotransduction, 2011, pp.474, 179~183
92. Halder G, "Transduction of mechanical and cytoskeletal cues by YAP and TAZ", Nat Rev Mol Cell Biol, 13, pp.591~600 (2012)[DOI]
93. Panciera T, "Mechanobiology of YAP and TAZ in physiology and disease", Nat Rev Mol Cell Biol, 12, pp.758~770 (2017)
94. Zhao B, "Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis", Genes Dev, 26, pp.54~68 (2012)[DOI]
95. Kim NG, "Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway", J Cell Biol, 210, pp.503~515 (2015)[DOI]
96. Elosegui-Artola A, "Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores", Cell, 171, pp.1397~1410 (2017)[DOI]
97. 모정순, "The role of extracellular biophysical cues in modulating the Hippo-YAP pathway", BMB Reports, 50(2), pp.71~78 (2017), 생화학분자생물학회
98. Wang Z, "Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility", Proc Natl Acad Sci U S A, 111, pp.89~98 (2014)[DOI]
99. Sorrentino G, "Metabolic control of YAP and TAZ by the mevalonate pathway", Nat Cell Biol, 16, pp.357~366 (2014)[DOI]
100. Mo JS, "Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway", Nat Cell Biol, 17, pp.500~510 (2015)[DOI]
101. Wang W, "AMPK modulates Hippo pathway activity to regulate energy homeostasis", Nat Cell Biol, 17, pp.490~499 (2015)[DOI]
102. Zhang X, "The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis", Nat Commun, 8, pp.15280~ (2017)[DOI]
103. Peng C, "Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation", Mol Cell, 68, pp.591~604 (2017)[DOI]
104. Ma B, "Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase", Nat Cell Biol, 17, pp.95~103 (2015)
105. Ma X, "Hypoxia-inducible factor 2alpha (HIF-2alpha) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity", J Biol Chem, 292, pp.17046~17056 (2017)[DOI]
106. Xiang L, "Hypoxiainducible factor 1 mediates TAZ expression and nuclear localization to induce the breast cancer stem cell phenotype", Oncotarget, 5, pp.12509~12527 (2014)
107. Ma B, "Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-beta signalling pathways", Nat Commun, 7, pp.11123~ (2016)[DOI]
108. Hong AW, "Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP", EMBO Rep, 18, pp.72~86 (2017)[DOI]
109. Lin KC, "Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation", Nat Cell Biol, 19, pp.996~1002 (2017)[DOI]
110. Taylor LK, "Newly identified stress-responsive protein kinases, Krs-1 and Krs-2", Proc Natl Acad Sci U S A, 93, pp.10099~10104 (1996)[DOI]
111. Lehtinen MK, "A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span", Cell, 125, pp.987~1001 (2006)[DOI]
112. Shao D, "A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response", Nat Commun, 5, pp.3315~ (2014)
113. Nusse R, "Wnt", beta-Catenin Signaling, Disease, and Emerging Therapeutic Modalities, 2017, pp.169, 985~999
114. Kim W, "Wnt", beta-catenin signalling: from plasma membrane to nucleus, 2013, pp.450, 9~21
115. Varelas X, "The Hippo pathway regulates Wnt", beta-catenin signaling, 2010, pp.18, 579~591
116. Imajo M, "A molecular mechanism that links Hippo signalling to the inhibition of Wnt", beta-catenin signalling, 2012, pp.31, 1109~1122
117. Barry ER, "Restriction of intestinal stem cell expansion and the regenerative response by YAP", Nature, 493, pp.106~110 (2013)
118. Tsutsumi R, "YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function", Dev Cell, 26, pp.658~665 (2013)[DOI]
119. Heallen T, "Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size", Science, 332, pp.458~461 (2011)[DOI]
120. Kim W, "Hippo signaling interactions with Wnt", beta-catenin and Notch signaling repress liver tumorigenesis, 2017, pp.127, 137~152
121. Fitamant J, "YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression", Cell Rep, 10, pp.1692~1707 (2015)[DOI]
122. Azzolin L, "Role of TAZ as mediator of Wnt signaling", Cell, 151, pp.1443~1456 (2012)[DOI]
123. Azzolin L, "YAP", TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response, 2014, pp.158, 157~170
124. Cai J, "beta-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis", Genes Dev, 29, pp.1493~1506 (2015)[DOI]
125. Yu FX, "Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling", Cell, 150, pp.780~791 (2012)[DOI]
126. Miller E, "Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP", Chem Biol, 19, pp.955~962 (2012)[DOI]
127. Park HW, "Alternative Wnt Signaling Activates YAP", TAZ, 2015, pp.162, 780~794
128. Struhl G, "Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo", Cell, 74, pp.331~345 (1993)[DOI]
129. Schroeter EH, "Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain", Nature, 393, pp.382~386 (1998)[DOI]
130. Bray SJ, "Notch signalling in context", Nat Rev Mol Cell Biol, 17, pp.722~735 (2016)[DOI]
131. Meignin C, "The salvador-warts-hippo pathway is required for epithelial proliferation and axis specification in Drosophila", Curr Biol, 17, pp.1871~1878 (2007)[DOI]
132. Polesello C, "Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch", Curr Biol, 17, pp.1864~1870 (2007)[DOI]
133. Camargo FD, "YAP1 increases organ size and expands undifferentiated progenitor cells", Curr Biol, 17, pp.2054~2060 (2007)[DOI]
134. Zhou D, "Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance", Proc Natl Acad Sci U S A, 108, pp.E1312~E1320 (2011)[DOI]
135. Yimlamai D, "Hippo pathway activity influences liver cell fate", Cell, 157, pp.1324~1338 (2014)[DOI]
136. Manderfield LJ, "Hippo signaling is required for Notch-dependent smooth muscle differentiation of neural crest", Development, 142, pp.2962~2971 (2015)[DOI]
137. Rayon T, "Notch and hippo converge on Cdx2 to specify the trophectoderm lineage in the mouse blastocyst", Dev Cell, 30, pp.410~422 (2014)[DOI]
138. Tschaharganeh DF, "Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma", Gastroenterology, 144, pp.1530~1542 (2013)[DOI]
139. Massague J, "TGFbeta signalling in context", Nat Rev Mol Cell Biol, 13, pp.616~630 (2012)[DOI]
140. Luo K, "Signaling Cross Talk between TGF-beta", Smad and Other Signaling Pathways, 2017, pp.9, a022137~
141. Ayyaz A, "Recent advances in understanding contextual TGFbeta signaling", F1000Res, 6, pp.749~ (2017)[DOI]
142. Attisano L, "Signal integration in TGF-beta, WNT, and Hippo pathways", F1000Prime Rep, 5, pp.17~ (2013)
143. Varelas X, "TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal", Nat Cell Biol, 10, pp.837~848 (2008)[DOI]
144. Nallet-Staub F, "Cell density sensing alters TGF-beta signaling in a cell-type-specific manner, independent from Hippo pathway activation", Dev Cell, 32, pp.640~651 (2015)[DOI]
145. Mahoney JE, "The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors", Dev Cell, 30, pp.137~150 (2014)[DOI]
146. Zhao R, "Yap tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal of stem cells", Dev Cell, 30, pp.151~165 (2014)[DOI]
147. Lee DH, "LATS-YAP", TAZ controls lineage specification by regulating TGFbeta signaling and Hnf4alpha expression during liver development, 2016, pp.7, 11961~
148. Lai D, "BMP4 is a novel transcriptional target and mediator of mammary cell migration downstream of the Hippo pathway component TAZ", Cell Signal, 25, pp.1720~1728 (2013)[DOI]
149. Nishio M, "Dysregulated YAP1", TAZ and TGF-beta signaling mediate hepatocarcinogenesis in Mob1a, Proc Natl Acad Sci U S A, pp.2016, 113[DOI]
150. Pefani DE, "TGF-beta Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP", SMAD2 Nuclear Translocation, 2016, pp.63, 156~166
151. Stroschein SL, "Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein", Science, 286, pp.771~774 (1999)[DOI]
152. Zhu Q, "SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis", Dev Cell, 37, pp.399~412 (2016)[DOI]

관련 논문AI추천